Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ SARS-CoV-2 medication

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses – Potential therapeutic strategies against COVID-19

COVID-19: Knowns, Unknowns, and Questions – (vi) Can we find therapeutic options? :::

COVID-19: Knowns, Unknowns, and Questions – (viii) What is the host response to SARS-CoV-2 and pathology of COVID-19? :::

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses – Vaccines for SARS-CoV-2

SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat – Chemotherapeutic options for SARS-CoV-2 infection

SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat – Conclusion remarks

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status – Antiviral treatments

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status – Current therapies

COVID-19: what has been learned and to be learned about the novel coronavirus disease – Antiviral therapy

COVID-19: what has been learned and to be learned about the novel coronavirus disease – Tackling cytokine storms

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective – Conventional treatment of SARS-CoV-2: is there a room for Chinese medicine?

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 – Conclusion

Molecular mechanisms of severe acute respiratory syndrome (SARS) – Vaccines against the SARS virus

Molecular mechanisms of severe acute respiratory syndrome (SARS) – Epitope-based vaccines

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 – Perspectives on the development of neutralizing antibodies against SARS-CoV-2

A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology – Before coming to hospital

From SARS to MERS, Thrusting Coronaviruses into the Spotlight – 8. Outlook and Summary

Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV) – Methods

Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV) – Conclusion

A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology – Entering the clinic room

From SARS to MERS, Thrusting Coronaviruses into the Spotlight – 5.4. S Protein-Based Therapeutics for SARS-CoV and MERS-CoV

Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model – Ethics Statement

The battle against SARS and MERS coronaviruses: Reservoirs and Animal Models – Common marmoset

SARS-CoV-2 and COVID-19: The most important research questions